Literature DB >> 10847789

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact.

C R King, C S Mayo.   

Abstract

Mesh：

Year:  2000        PMID： 10847789     DOI： 10.1016/s0360-3016(00)00442-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost.

Authors:  Philip S Boonstra; Jeremy M G Taylor; Beata Smolska-Ciszewska; Katarzyna Behrendt; Tomasz Dworzecki; Marzena Gawkowska-Suwinska; Brygida Bialas; Rafal Suwinski
Journal:  Br J Radiol       Date:  2016-02-23       Impact factor: 3.039

2.  Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

Authors:  Jeffrey V Brower; Jeffrey D Forman; Patrick A Kupelian; Daniel G Petereit; Vinai Gondi; Colleen A Lawton; Nick Anger; Sandeep Saha; Rick Chappell; Mark A Ritter
Journal:  Radiother Oncol       Date:  2016-01-02       Impact factor: 6.280

3.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.

Authors:  Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Andre A Konski; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; C-M Charlie Ma; Shawn W McNeeley; Mark K Buyyounouski; Robert A Price
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-19       Impact factor: 7.038

Review 4.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

5.  Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.

Authors:  Olivier Chapet; Corina Udrescu; Sylvie Bin; Evelyne Decullier; Pascal Fenoglietto; Amandine Beneux; Bruno Segui; Ciprian Enachescu; Sonya Gaudioz; Alain Ruffion; David Azria
Journal:  Br J Radiol       Date:  2021-08-01       Impact factor: 3.629

Review 6.  Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.

Authors:  M Mangoni; I Desideri; B Detti; P Bonomo; D Greto; F Paiar; G Simontacchi; I Meattini; S Scoccianti; T Masoni; C Ciabatti; A Turkaj; S Serni; A Minervini; M Gacci; M Carini; L Livi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

Review 7.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

Authors:  C M van Leeuwen; A L Oei; J Crezee; A Bel; N A P Franken; L J A Stalpers; H P Kok
Journal:  Radiat Oncol       Date:  2018-05-16       Impact factor: 3.481
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.